0
0
0
0
#lcsm
Latest posts tagged with #lcsm on Bluesky
Posts tagged #lcsm
Melissa Crouse ran out of time on April 6. She was a 20 year survivor of Stage IV Lung Cancer. Melissa was a mother, grandmother, fierce advocate, friend and beacon of hope. See you on the other side. 💔 #lcsm
2
1
1
0
Shared with thanks and respect from our colleagues at the Lung Cancer Policy Network:
LDCT screening for lung cancer enables earlier diagnosis and better outcomes. Could it also detect other diseases with similar risk factors? More: t.co/SmQndTgTF7
#LCSM #lungcancer
0
0
0
0
Welcome to the #AYACSM (Adolescent and Young Adult Cancer Societal Movement) #SkyChat! This year we are celebrating 12 YEARS OF #AYACSM CHATS!!
#BTSM #BCSM #LCSM #YACancer #AYACancer #AYAware
2
0
0
1
A new @cellpress.bsky.social perspective looks at why more cancers are being diagnosed in younger adults.
For #lungcancer, it adds to wider thinking that risk may be shaped across life by environment, inflammation and timing of exposure. #LCSM
www.cell.com/cell/fulltex...
3
1
0
0
In this UK NHS #LungCancer trial, AI cut chest X-ray reporting time, but not time to CT, diagnosis or treatment. Faster reporting alone does not fix a slow lung cancer pathway. The hold-up comes in what happens after the X-ray. #LCSM
ascoai.org/articles/202...
4
0
0
0
A new peer reviewed paper has added weight to concerns about vaping and cancer risk. It says nicotine-based e-cigarettes are likely to be carcinogenic, with likely links to #lungcancer and oral cancer.
Find out what the evidence now says 👉 www.lungcancereuropenews.eu/news/can-vap...
#LCSM
3
0
0
0
We’re delighted to announce Dr Tom Newsom-Davis as keynote speaker at our 5th ALK+ UK National Conference. 💙
Join us in London 25–27 Sept for a weekend of expert talks, trusted information & time to connect with others in the ALK+ #LungCancer community #LCSM
www.alkpositive.org.uk/national-con...
4
0
0
0
2
1
0
0
A positive EMA recommendation for tarlatamab marks an important step for relapsed extensive-stage SCLC in Europe. For people facing a disease with limited options after relapse, this matters. Now the focus must also be on fair & timely access. #LCSM
www.lungcancereuropenews.eu/news/ema-rec...
5
1
0
0
A study shows that an AI pathology tool predicts whether a patient with extensive-stage small cell lung cancer will respond to platinum-based chemotherapy. @roswellpark.bsky.social #lcsm #oncology
www.onclive.com/view/new-ai-...
0
0
0
0
Lurbinectedin plus atezolizumab received CHMP recommendation as first-line maintenance for ES-SCLC that has not progressed following induction therapy.
#oncology #lcsm #SCLC
www.onclive.com/view/chmp-re...
0
0
0
0
ELCC is always an important meeting for us, but this year felt esp significant. For the 1st time, we launched our annual #LungCancer report during ELCC - a big change for us, & it felt like the right move.
It was also chance to introduce some of our new team & spend time with supporters. #LCSM
4
0
0
0
New March 2026 data from Cancer Research UK shows #lungcancer death rates in the UK have fallen by 22% over the past decade.
But the picture is very different for men and women. Over the last decade, lung cancer incidence rates rose by 8% in women, while falling by 13% in men.
#LCSM
4
0
0
0
A 🆕 article in Lung Cancer adds more detail from the ALINA trial, showing that adjuvant alectinib continued to show disease-free survival benefit over chemo across surgical subgroups in resected early-stage ALK+ #LungCancer. ALINA isn’t new, but this gives a closer look at who benefited. #LCSM
4
0
0
0
WATCH: Fred R. Hirsch, MD, PhD, of @mountsinainyc.bsky.social discusses research validating an AI-assisted PD-L1 scoring algorithm against original Blueprint study data in lung cancer. #ELCC26 #lcsm #lungcancer #AI
www.onclive.com/view/dr-hirs...
0
1
0
0
WATCH: Nicolas Girard, MD, PhD, of @institutcurie.bsky.social discusses updated data from the phase 2 PALOMA-2 trial that were presented at the 2026 European Lung Cancer Congress. #ELCC26 #ELCC2026 #lcsm #lungcancer
www.onclive.com/view/dr-gira...
1
0
0
0
🫁 The European Medicines Agency’s CHMP has recommended granting marketing authorization for tarlatamab monotherapy in adults with ES-SCLC whose disease progresses during or after platinum-based chemotherapy.
#LungCancer #SCLC #lcsm #Oncology
www.onclive.com/view/chmp-re...
0
0
0
0
🫁Calderasib showed strong efficacy, with ORRs up to 72% in combination with pembrolizumab in patients with KRAS G12C–mutant metastatic NSCLC. @myesmo.bsky.social
#ELCC26 #lcsm
www.onclive.com/view/caldera...
0
0
0
0
🫁Calderasib showed strong efficacy, with ORRs up to 72% in combination with pembrolizumab in patients with KRAS G12C–mutant metastatic NSCLC. @myESMO
#ELCC26 #lcsm
www.onclive.com/view/caldera...
1
0
0
0
Jessica Donington, MD, MSCR, of @uchicagocancer.bsky.social disusses some of the logistical challenges that accompany the integration of biomarker testing into early-stage workflows. #oncology #lcsm #lungcancer
www.onclive.com/view/surgica...
1
1
0
0
Adagrasib shows differentiated activity in KRAS G12C–mutant NSCLC 🔬
In ADEPPT, elderly patients with ECOG 0-1 saw meaningful, durable responses, while those with ECOG 2 had limited benefit despite some QOL gains.
Learn more: www.onclive.com/view/ecog-pe...
@myesmo.bsky.social #ELCC26 #lcsm
0
0
0
0
What did 140 people affected by Small Cell #LungCancer tell us about the impact of diagnosis on mental health?
We share findings tonight in Copenhagen at 18:15, alongside our 11th Report. Join us for the discussion & be among the first to pick up a copy. www.tickettailor.com/events/lungc... #LCSM
6
0
0
0
Setidegrasib yielded antitumor activity with a tolerable safety profile in KRAS G12D-mutated NSCLC. @myesmo.bsky.social #ELCC26 #ELCC2026 #lcsm #oncology
www.onclive.com/view/setideg...
1
0
0
0
Osimertinib plus chemotherapy prolonged PFS vs osimertinib alone in patients with advanced NSCLC harboring concurrent EGFR and TP53 mutations.
@myesmo.bsky.social
#ELCC26 #ELCC2026 #lcsm #oncology
www.onclive.com/view/osimert...
0
0
0
0
Frontline iza-bren in combination with serplulimab was associated with a tolerable and manageable safety profile and elicited responses in ES-SCLC. @myesmo.bsky.social #ELCC26 #ELCC2026 #lcsm #oncology
www.onclive.com/view/first-l...
0
0
0
0
Interesting to see Ben Solomon speak about early immune-based approaches in ALK+ lung cancer at #ELCC26.
Alongside TKIs, researchers are also looking at whether the immune system could be better engaged in ALK+ #lungcancer, including through ALK vaccines and ALK-specific T cell approaches. #LCSM
5
0
0
0
#ELCC26 is underway in Copenhagen.
We’re at stand D352 - come & say hi 👋
We’re talking mental health, lived experience, & what needs to change in #lungcancer care across Europe.
It’s not too late to get a ticket to our 11th Report Launch on Thurs eve www.tickettailor.com/events/lungc...
#LCSM
5
0
0
0
Ahead of ELCC 2026, we spoke with expert lung cancer clinicians to gain their insights into the most anticipated abstracts that will be presented at the meeting.
🔒 Sign up here to read: www.onclive.com/view/thoraci...
#oncology #ELCC2026 #lungcancer #NSCLC #lcsm
0
0
0
0
A poignant read in this weekend’s Guardian. Janis Chen writes about living with stage 4 #lungcancer and the in-between space that can come with it - ongoing treatment, uncertainty, fatigue, scanxiety, and trying to keep living around all of that. #LCSM
www.theguardian.com/society/2026...
7
2
0
0